These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 16718812)

  • 21. Immunotherapeutic interventions in chronic hepatitis B virus infection: a review.
    Wang L; Zou ZQ; Liu CX; Liu XZ
    J Immunol Methods; 2014 May; 407():1-8. PubMed ID: 24747918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-cell therapy for chronic viral hepatitis.
    Bertoletti A; Tan AT; Koh S
    Cytotherapy; 2017 Nov; 19(11):1317-1324. PubMed ID: 28847469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of psoriasis patients with hepatitis B or hepatitis C virus infection.
    Bonifati C; Lora V; Graceffa D; Nosotti L
    World J Gastroenterol; 2016 Jul; 22(28):6444-55. PubMed ID: 27605880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro use of autologous dendritic cells improves detection of T cell responses to hepatitis B virus (HBV) antigens.
    Carotenuto P; Artsen A; Niesters HG; Osterhaus AD; Pontesilli O
    J Med Virol; 2009 Feb; 81(2):332-9. PubMed ID: 19107973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic vaccination in the immunotolerant phase of children with chronic hepatitis B infection.
    Dikici B; Kalayci AG; Ozgenc F; Bosnak M; Davutoglu M; Ece A; Ozkan T; Ozeke T; Yagci RV; Haspolat K
    Pediatr Infect Dis J; 2003 Apr; 22(4):345-9. PubMed ID: 12690275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of chronic hepatitis B in children.
    Shah U; Kelly D; Chang MH; Fujisawa T; Heller S; González-Peralta RP; Jara P; Mieli-Vergani G; Mohan N; Murray KF
    J Pediatr Gastroenterol Nutr; 2009 Apr; 48(4):399-404. PubMed ID: 19322053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B.
    Lebossé F; Testoni B; Fresquet J; Facchetti F; Galmozzi E; Fournier M; Hervieu V; Berthillon P; Berby F; Bordes I; Durantel D; Levrero M; Lampertico P; Zoulim F
    J Hepatol; 2017 May; 66(5):897-909. PubMed ID: 28043874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toward Curative Immunomodulation Strategies for Chronic Hepatitis B Virus Infection.
    Zhu W; Liu H; Zhang X
    ACS Infect Dis; 2019 May; 5(5):703-712. PubMed ID: 30907080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Future considerations for dendritic cell immunotherapy against chronic viral infections.
    Atanley E; van Drunen Littel-van den Hurk S
    Expert Rev Clin Immunol; 2014 Jun; 10(6):801-13. PubMed ID: 24734867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Engineering immune therapy against hepatitis B virus.
    Akbar F; Yoshida O; Abe M; Hiasa Y; Onji M
    Hepatol Res; 2007 Oct; 37 Suppl 3():S351-6. PubMed ID: 17931186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interplay between hepatitis B virus and the innate immune responses: implications for new therapeutic strategies.
    Chen J; Yuan Z
    Virol Sin; 2014 Feb; 29(1):17-24. PubMed ID: 24452540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection.
    Reynolds TD; Buonocore L; Rose NF; Rose JK; Robek MD
    J Virol; 2015 Oct; 89(20):10407-15. PubMed ID: 26246574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of DCs in the immunopathogenesis of chronic HBV infection and the methods of inducing DCs maturation.
    Sun HH; Zhou DF; Zhou JY
    J Med Virol; 2016 Jan; 88(1):13-20. PubMed ID: 26104380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers.
    Mancini-Bourgine M; Fontaine H; Scott-Algara D; Pol S; Bréchot C; Michel ML
    Hepatology; 2004 Oct; 40(4):874-82. PubMed ID: 15382173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection.
    Martinet J; Leroy V; Dufeu-Duchesne T; Larrat S; Richard MJ; Zoulim F; Plumas J; Aspord C
    Hepatology; 2012 Nov; 56(5):1706-18. PubMed ID: 22707082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrahepatic Cross-Presentation and Hepatocellular Antigen Presentation Play Distinct Roles in the Induction of Hepatitis B Virus-Specific CD8
    Murata Y; Kawashima K; Sheikh K; Tanaka Y; Isogawa M
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30089700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotherapy of chronic hepatitis B by anti HBV vaccine: from present to future.
    Michel ML; Pol S; Brechot C; Tiollais P
    Vaccine; 2001 Mar; 19(17-19):2395-9. PubMed ID: 11257367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and immunogenicity of therapeutic DNA vaccine with antiviral drug in chronic HBV patients and its immunogenicity in mice.
    Yoon SK; Seo YB; Im SJ; Bae SH; Song MJ; You CR; Jang JW; Yang SH; Suh YS; Song JS; Kim BM; Kim CY; Jeong SH; Sung YC
    Liver Int; 2015 Mar; 35(3):805-15. PubMed ID: 24620920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective functional deficit in dendritic cell--T cell interaction is a crucial mechanism in chronic hepatitis B virus infection.
    Zheng BJ; Zhou J; Qu D; Siu KL; Lam TW; Lo HY; Lee SS; Wen YM
    J Viral Hepat; 2004 May; 11(3):217-24. PubMed ID: 15117323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune function of plasmacytoid dendritic cells, natural killer cells, and their crosstalk in HBV infection.
    Golsaz-Shirazi F; Amiri MM; Shokri F
    Rev Med Virol; 2018 Nov; 28(6):e2007. PubMed ID: 30175481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.